Brokerages Anticipate ConforMIS Inc (NASDAQ:CFMS) Will Post Earnings of -$0.10 Per Share

Share on StockTwits

Equities research analysts expect ConforMIS Inc (NASDAQ:CFMS) to post ($0.10) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for ConforMIS’s earnings, with estimates ranging from ($0.11) to ($0.09). ConforMIS reported earnings per share of ($0.16) in the same quarter last year, which would indicate a positive year-over-year growth rate of 37.5%. The firm is expected to report its next quarterly earnings results on Wednesday, February 5th.

On average, analysts expect that ConforMIS will report full year earnings of ($0.46) per share for the current year, with EPS estimates ranging from ($0.47) to ($0.45). For the next financial year, analysts anticipate that the company will post earnings of ($0.35) per share, with EPS estimates ranging from ($0.37) to ($0.34). Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow ConforMIS.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings results on Wednesday, October 30th. The medical instruments supplier reported ($0.13) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.11) by ($0.02). The company had revenue of $17.30 million during the quarter, compared to analyst estimates of $17.80 million. ConforMIS had a negative net margin of 41.36% and a negative return on equity of 115.71%.

Several research analysts have commented on CFMS shares. ValuEngine cut shares of ConforMIS from a “sell” rating to a “strong sell” rating in a report on Wednesday, October 2nd. Zacks Investment Research lowered shares of ConforMIS from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $3.33.

NASDAQ CFMS traded down $0.07 on Wednesday, hitting $1.49. 1,660,759 shares of the company were exchanged, compared to its average volume of 1,181,342. The company’s 50 day moving average price is $1.90 and its 200-day moving average price is $2.59. The company has a debt-to-equity ratio of 1.83, a current ratio of 3.11 and a quick ratio of 2.43. The firm has a market capitalization of $103.07 million, a P/E ratio of -2.01 and a beta of 2.29. ConforMIS has a twelve month low of $0.36 and a twelve month high of $4.83.

A number of institutional investors have recently made changes to their positions in the stock. Bank of Montreal Can acquired a new stake in ConforMIS during the 2nd quarter worth about $27,000. LPL Financial LLC increased its holdings in shares of ConforMIS by 65.9% in the 2nd quarter. LPL Financial LLC now owns 16,752 shares of the medical instruments supplier’s stock valued at $73,000 after purchasing an additional 6,652 shares during the period. Steward Partners Investment Advisory LLC acquired a new position in shares of ConforMIS in the 2nd quarter valued at about $44,000. Private Advisor Group LLC purchased a new stake in shares of ConforMIS in the second quarter worth approximately $52,000. Finally, GSA Capital Partners LLP purchased a new stake in shares of ConforMIS in the second quarter worth approximately $59,000. 45.69% of the stock is owned by hedge funds and other institutional investors.

ConforMIS Company Profile

Conformis, Inc, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee.

Featured Article: Insider Trading

Get a free copy of the Zacks research report on ConforMIS (CFMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for ConforMIS (NASDAQ:CFMS)

Receive News & Ratings for ConforMIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.